Sotorasib Clinical Trial for KRAS G12C-Mutated Metastatic Colorectal Cancer

ClinicalTrials.gov identifier: NCT06252649

This Phase 3 clinical study evaluates sotorasib, panitumumab, and FOLFIRI versus FOLFIRI with or without bevacizumab-awwb in previously untreated metastatic colorectal cancer with a KRAS G12C mutation.

Study availability and enrollment status may change. A California Research Institute coordinator can confirm current local availability and explain the screening process.

Request study information